Overview

Bevacizumab for Primary Pterygium Treatment

Status:
Completed

Trial end date:
2012-02-01

Target enrollment:

Participant gender:

Summary

The aim of this study was to investigate the efficacy and safety of subconjunctival bevacizumab application as an adjuvant therapy for primary pterygium.

Phase:

Phase 1

Details

Lead Sponsor:

Instituto de Oftalmología Fundación Conde de Valenciana

Treatments:

Bevacizumab